Go Pro

Immuron (IMRN) Financials

Immuron logo
$1.82 +0.03 (+1.39%)
Closing price 03:59 PM Eastern
Extended Trading
$1.82 0.00 (-0.27%)
As of 04:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Immuron

Annual Income Statements for Immuron

This table shows Immuron's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders
-5.30 -5.20 -2.27 -3.27 -2.02 -6.31 -1.97 -2.46 -4.26 -3.43
Consolidated Net Income / (Loss)
-5.30 -5.23 -2.27 -3.27 -2.02 -6.30 -1.97 -2.52 -4.63 -3.43
Net Income / (Loss) Continuing Operations
-5.30 -5.23 -2.27 -3.27 -2.02 -6.30 -1.97 -2.46 -4.26 -3.43
Total Pre-Tax Income
-5.30 -5.23 -2.27 -3.27 -2.02 -6.30 -1.97 -2.52 -4.63 -3.43
Total Operating Income
-5.30 -5.17 -2.26 -3.64 -2.01 -6.30 -1.98 -2.38 -3.87 -3.51
Total Gross Profit
0.52 0.81 1.06 1.20 1.27 0.07 0.36 0.87 2.23 3.13
Total Revenue
1.91 1.07 1.37 1.66 1.74 0.11 0.53 1.20 3.27 4.79
Operating Revenue
1.91 1.07 1.37 1.66 1.74 0.11 0.53 1.20 3.27 4.79
Total Cost of Revenue
0.58 0.26 0.31 1.40 0.48 0.04 0.17 0.33 1.05 1.66
Operating Cost of Revenue
0.58 0.26 0.31 1.40 0.48 0.04 0.17 0.33 1.05 1.66
Total Operating Expenses
6.62 6.93 3.31 3.90 3.27 6.39 2.34 3.19 5.73 6.65
Selling, General & Admin Expense
1.09 2.39 2.57 2.57 2.19 4.58 2.43 2.81 3.04 2.95
Marketing Expense
0.37 0.98 0.51 0.60 0.60 0.22 0.29 0.62 1.36 2.27
Research & Development Expense
2.72 3.56 1.67 0.73 0.82 1.03 0.45 1.73 3.59 2.36
Other Operating Expenses / (Income)
2.44 - -1.44 - -0.34 - -0.83 -1.97 -2.26 -0.94
Total Other Income / (Expense), net
0.01 0.88 0.00 0.37 0.00 0.03 0.01 -0.15 -0.76 0.08
Interest Expense
- 0.07 - - - - 0.00 0.01 0.01 0.00
Interest & Investment Income
- 0.01 - - - - 0.02 0.08 0.22 0.09
Other Income / (Expense), net
0.01 0.95 - 0.37 - 0.03 0.00 -0.22 -0.97 0.00
Income Tax Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00
Basic Earnings per Share
- ($6.40) - - ($1.66) ($3.79) ($0.86) ($1.11) ($2.03) ($1.49)
Weighted Average Basic Shares Outstanding
- - 142.78M 163.22M 178.28M 227.25M 227.80M 227.80M 228.00M 233.96M
Diluted Earnings per Share
- ($6.40) - - - - - ($1.11) ($2.03) ($1.49)
Weighted Average Diluted Shares Outstanding
- - 142.78M 163.22M 178.28M 227.25M 227.80M 227.80M 228.00M 233.96M
Weighted Average Basic & Diluted Shares Outstanding
- - 142.78M 163.22M 178.28M 227.25M 227.80M 227.80M 228.00M 233.96M

Quarterly Income Statements for Immuron

No quarterly income statements for Immuron are available.


Annual Cash Flow Statements for Immuron

This table details how cash moves in and out of Immuron's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Change in Cash & Equivalents
-2.02 7.89 3.39 2.02 1.35 22 -2.19 -0.18 -3.71 -5.81
Net Cash From Operating Activities
-4.71 9.55 -0.02 0.00 0.00 -0.01 -2.17 -0.17 -3.93 -4.03
Net Cash From Continuing Operating Activities
-4.71 9.55 -0.02 0.00 0.00 -0.01 -0.21 -0.17 -0.26 -0.51
Net Income / (Loss) Continuing Operations
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Non-Cash Adjustments To Reconcile Net Income
-4.71 9.55 -0.02 - - -0.01 -0.21 -0.01 -0.26 -0.51
Net Cash From Investing Activities
2.70 -0.00 4.05 2.02 1.35 22 0.01 -0.01 0.22 -1.91
Net Cash From Continuing Investing Activities
2.70 -0.00 4.05 2.02 1.35 22 0.01 -0.01 0.22 -1.91
Purchase of Property, Plant & Equipment
- - - - - - -0.01 - -0.00 0.00
Purchase of Investments
- - - - - - - 0.00 0.00 -2.00
Sale and/or Maturity of Investments
1.86 - 4.06 2.02 1.35 22 0.02 - 0.22 0.09
Net Cash From Financing Activities
0.00 -1.68 -0.64 0.00 0.00 -0.16 -0.03 0.00 0.00 0.13
Net Cash From Continuing Financing Activities
0.00 -1.68 -0.64 0.00 0.00 -0.16 -0.03 0.00 0.00 0.13
Repayment of Debt
- - - - - - -0.03 - -0.02 -0.05
Repurchase of Common Equity
- - - - - - - - 0.00 -0.08
Other Financing Activities, net
- - - - - - - - 0.02 0.26

Quarterly Cash Flow Statements for Immuron

No quarterly cash flow statements for Immuron are available.


Annual Balance Sheets for Immuron

This table presents Immuron's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Total Assets
6.37 6.85 5.96 4.29 20 17 15 10 6.66
Total Current Assets
6.35 5.23 4.65 3.05 19 16 14 9.83 6.58
Cash & Equivalents
3.07 3.50 3.57 2.25 19 15 11 7.78 1.86
Accounts Receivable
1.36 1.25 0.67 0.23 0.25 0.46 0.28 0.93 1.27
Inventories, net
1.80 0.37 0.38 1.74 0.22 0.23 0.56 1.06 1.16
Other Current Assets
0.13 0.11 0.03 0.02 0.06 0.40 1.33 0.06 2.29
Plant, Property, & Equipment, net
0.01 0.02 0.01 0.05 0.03 0.16 0.13 0.10 0.07
Plant, Property & Equipment, gross
0.01 0.02 0.01 0.05 0.03 0.16 0.13 0.10 0.07
Total Noncurrent Assets
0.00 1.61 1.30 0.00 0.95 0.66 0.92 0.45 0.00
Other Noncurrent Operating Assets
0.00 1.61 1.30 - 0.95 0.66 0.81 0.45 0.00
Total Liabilities & Shareholders' Equity
6.17 7.13 5.88 4.21 20 17 14 10 6.66
Total Liabilities
1.32 0.60 0.84 0.39 0.87 1.16 1.58 1.90 1.35
Total Current Liabilities
1.32 0.60 0.83 0.36 0.84 1.04 1.48 1.80 1.29
Accounts Payable
0.99 0.51 0.76 0.27 0.57 0.80 0.79 1.43 1.01
Other Taxes Payable
- - - - - - - 0.35 0.26
Other Current Liabilities
- 0.00 0.00 0.03 0.02 0.02 0.03 0.03 0.03
Total Noncurrent Liabilities
0.00 0.00 0.01 0.03 0.03 0.12 0.10 0.09 0.06
Noncurrent Employee Benefit Liabilities
- - - - - - 0.00 0.01 0.01
Other Noncurrent Operating Liabilities
- 0.00 0.00 0.01 0.00 0.12 0.10 0.09 0.05
Total Equity & Noncontrolling Interests
5.05 6.26 5.12 3.90 19 16 13 8.49 5.30
Total Preferred & Common Equity
5.05 6.62 5.12 3.90 19 16 13 8.49 5.30
Total Common Equity
5.05 6.62 5.12 3.90 19 16 13 8.49 5.30
Common Stock
41 43 42 43 66 61 59 59 58
Retained Earnings
-38 -39 -40 -40 -50 -47 -48 -53 -54
Other Equity Adjustments
1.90 2.30 3.00 0.78 2.60 2.19 2.16 2.12 1.08

Quarterly Balance Sheets for Immuron

No quarterly balance sheets for Immuron are available.


Annual Metrics And Ratios for Immuron

This table displays calculated financial ratios and metrics derived from Immuron's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
DEI Shares Outstanding
0.00 0.00 142,778,206.00 163,215,706.00 178,279,566.00 227,246,596.00 227,798,346.00 227,798,346.00 227,998,346.00 227,998,346.00
DEI Adjusted Shares Outstanding
0.00 0.00 142,778,206.00 163,215,706.00 178,279,566.00 227,246,596.00 227,798,346.00 227,798,346.00 227,998,346.00 227,998,346.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 -0.02 -0.02 -0.01 -0.03 -0.01 -0.01 -0.02 -0.02
Growth Metrics
- - - - - - - - - -
Revenue Growth
0.00% -43.68% 27.30% 21.71% 4.74% -93.71% 382.43% 127.58% 172.24% 46.31%
EBITDA Growth
0.00% 20.24% 46.52% -44.83% 38.55% -212.06% 68.39% -30.90% -86.80% 27.50%
EBIT Growth
0.00% 20.28% 46.52% -44.83% 38.55% -212.06% 68.39% -30.90% -86.80% 27.50%
NOPAT Growth
0.00% 2.54% 56.31% -61.24% 44.81% -213.35% 68.52% -20.00% -62.89% 9.31%
Net Income Growth
0.00% 1.37% 56.50% -43.74% 38.10% -211.20% 68.71% -28.01% -83.59% 25.98%
EPS Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -83.51% 26.82%
Operating Cash Flow Growth
0.00% 302.62% -100.19% 100.00% 0.00% 0.00% -20,922.84% 91.98% -2,152.16% -2.74%
Free Cash Flow Firm Growth
0.00% 0.00% 64.05% 36.52% -11.43% -128.61% 56.09% -84.14% 48.97% -266.83%
Invested Capital Growth
0.00% 0.00% 23.74% -42.30% 5.89% -56.05% 15.94% 126.06% -64.81% 390.14%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - -
Gross Margin
27.54% 75.82% 77.28% 72.05% 72.65% 64.97% 68.41% 72.54% 68.06% 65.39%
EBITDA Margin
-277.79% -393.38% -165.26% -196.65% -115.37% -5,724.77% -375.05% -215.72% -148.02% -73.34%
Operating Margin
-278.29% -481.51% -165.26% -218.93% -115.37% -5,748.50% -375.05% -197.75% -118.32% -73.34%
EBIT Margin
-277.94% -393.38% -165.26% -196.65% -115.37% -5,724.77% -375.05% -215.72% -148.02% -73.34%
Profit (Net Income) Margin
-278.29% -487.33% -166.51% -196.65% -116.23% -5,751.62% -373.01% -209.81% -141.49% -71.58%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
100.13% 123.88% 100.75% 100.00% 100.74% 100.47% 99.46% 97.26% 95.59% 97.59%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% -315.62% -61.64% -113.95% -83.48% -353.32% -168.67% -115.61% -200.93% -118.63%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -198.83% -39.17% -93.04% -61.62% -335.18% -165.22% -109.06% -180.56% -98.53%
Return on Net Nonoperating Assets (RNNOA)
0.00% 108.65% 21.41% 56.46% 38.61% 299.38% 157.56% 98.26% 157.95% 68.91%
Return on Equity (ROE)
0.00% -206.97% -40.23% -57.49% -44.87% -53.94% -11.12% -17.36% -42.97% -49.72%
Cash Return on Invested Capital (CROIC)
0.00% -515.62% -82.86% -60.31% -89.20% -275.44% -183.44% -192.94% -105.05% -250.85%
Operating Return on Assets (OROA)
0.00% -66.28% -34.15% -51.03% -39.20% -50.95% -10.57% -16.31% -38.71% -41.23%
Return on Assets (ROA)
0.00% -82.11% -34.41% -51.03% -39.49% -51.18% -10.51% -15.86% -37.01% -40.24%
Return on Common Equity (ROCE)
0.00% -206.97% -41.52% -59.32% -44.87% -53.94% -11.12% -17.36% -42.97% -49.72%
Return on Equity Simple (ROE_SIMPLE)
0.00% -103.49% -34.37% -63.87% -51.86% -32.38% -12.31% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-3.71 -3.62 -1.58 -2.55 -1.41 -4.41 -1.39 -1.66 -2.71 -2.46
NOPAT Margin
-194.80% -337.06% -115.68% -153.25% -80.76% -4,023.95% -262.53% -138.43% -82.82% -51.34%
Net Nonoperating Expense Percent (NNEP)
0.00% -116.79% -22.47% -20.90% -21.85% -18.14% -3.45% -6.55% -20.37% -20.10%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - -12.73% -31.95% -46.36%
Cost of Revenue to Revenue
30.63% 24.18% 22.72% 84.23% 27.35% 35.03% 31.59% 27.46% 31.94% 34.61%
SG&A Expenses to Revenue
57.26% 222.74% 188.30% 154.74% 125.87% 4,180.87% 460.59% 233.88% 92.92% 61.53%
R&D to Revenue
142.67% 331.66% 122.48% 43.75% 46.80% 937.78% 85.95% 143.63% 109.64% 49.37%
Operating Expenses to Revenue
347.66% 645.47% 242.54% 234.70% 188.02% 5,837.18% 443.46% 265.15% 175.00% 138.74%
Earnings before Interest and Taxes (EBIT)
-5.30 -4.22 -2.26 -3.27 -2.01 -6.27 -1.98 -2.59 -4.85 -3.51
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-5.29 -4.22 -2.26 -3.27 -2.01 -6.27 -1.98 -2.59 -4.85 -3.51
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 2.22 7.77 1.11 0.76 0.88 1.62 1.87
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 2.22 7.77 1.11 0.76 0.88 1.62 1.87
Price to Revenue (P/Rev)
0.00 0.00 0.00 6.85 17.41 197.37 23.01 9.57 4.21 2.07
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 4.78 16.20 3.67 0.00 0.00 8.54 2.34
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 4.70 16.12 25.55 0.00 0.00 1.83 1.68
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
0.00 -0.55 -0.55 -0.61 -0.63 -0.89 -0.95 -0.90 -0.87 -0.70
Leverage Ratio
0.00 1.26 1.17 1.13 1.14 1.05 1.06 1.09 1.16 1.24
Compound Leverage Factor
0.00 1.56 1.18 1.13 1.14 1.06 1.05 1.06 1.11 1.21
Debt to Total Capital
0.00% 2.08% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 2.08% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 97.92% 105.80% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 -0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.70 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 -0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.82 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
0.00 0.00 0.00 -2.02 33.66 11.58 3.16 0.27 -3.05 -7.07
Noncontrolling Interest Sharing Ratio
0.00% 0.00% -3.21% -3.19% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
0.00 4.83 8.78 5.59 8.54 22.96 15.75 9.20 5.46 5.09
Quick Ratio
0.00 3.37 7.98 5.09 6.93 22.63 15.15 7.92 4.83 2.42
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -5.91 -2.12 -1.35 -1.50 -3.44 -1.51 -2.78 -1.42 -5.20
Operating Cash Flow to CapEx
0.00% 218,191.46% -367.00% 0.00% 0.00% -207.57% -31,328.21% -3,381.09% -3,020,129.85% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 -85.75 0.00 0.00 0.00 0.00 -353.29 -431.94 -280.25 -1,082.85
Operating Cash Flow to Interest Expense
0.00 138.62 0.00 0.00 0.00 0.00 -509.03 -27.11 -776.23 -840.03
Operating Cash Flow Less CapEx to Interest Expense
0.00 138.56 0.00 0.00 0.00 0.00 -510.65 -27.91 -776.26 -840.03
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.00 0.17 0.21 0.26 0.34 0.01 0.03 0.08 0.26 0.56
Accounts Receivable Turnover
0.00 0.79 1.05 1.73 3.86 0.46 1.49 3.27 5.44 4.37
Inventory Turnover
0.00 0.14 0.29 3.74 0.45 0.04 0.75 0.84 1.29 1.49
Fixed Asset Turnover
0.00 74.12 92.34 122.95 57.22 2.95 5.81 8.30 27.70 53.83
Accounts Payable Turnover
0.00 0.26 0.41 2.20 0.93 0.09 0.24 0.41 0.94 1.36
Days Sales Outstanding (DSO)
0.00 462.26 348.25 211.02 94.46 796.61 244.96 111.68 67.15 83.53
Days Inventory Outstanding (DIO)
0.00 2,526.13 1,272.83 97.50 812.91 9,333.75 486.94 433.97 282.34 244.74
Days Payable Outstanding (DPO)
0.00 1,395.34 883.65 165.69 393.21 3,974.72 1,499.75 882.32 387.61 267.69
Cash Conversion Cycle (CCC)
0.00 1,593.05 737.43 142.83 514.16 6,155.64 -767.86 -336.66 -38.11 60.58
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
0.00 2.29 2.84 1.64 1.73 0.76 0.88 2.00 0.70 3.44
Invested Capital Turnover
0.00 0.94 0.53 0.74 1.03 0.09 0.64 0.84 2.43 2.31
Increase / (Decrease) in Invested Capital
0.00 2.29 0.54 -1.20 0.10 -0.97 0.12 1.11 -1.29 2.74
Enterprise Value (EV)
0.00 0.00 0.00 7.82 28 2.80 -3.11 -0.04 6.00 8.06
Market Capitalization
0.00 0.00 0.00 11 30 22 12 12 14 9.92
Book Value per Share
$0.00 $0.00 $0.05 $0.04 $0.02 $0.11 $0.07 $0.06 $0.04 $0.02
Tangible Book Value per Share
$0.00 $0.00 $0.05 $0.04 $0.02 $0.11 $0.07 $0.06 $0.04 $0.02
Total Capital
0.00 5.16 6.26 5.12 3.90 19 16 13 8.49 5.30
Total Debt
0.00 0.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
0.00 -2.96 -3.50 -3.57 -2.25 -19 -15 -12 -7.78 -1.86
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 2.08 1.13 0.26 0.44 -0.31 0.04 0.69 0.25 3.43
Debt-free Net Working Capital (DFNWC)
0.00 5.15 4.63 3.82 2.69 19 15 12 8.03 5.29
Net Working Capital (NWC)
0.00 5.04 4.63 3.82 2.69 19 15 12 8.03 5.29
Net Nonoperating Expense (NNE)
1.59 1.61 0.69 0.72 0.62 1.89 0.58 0.86 1.92 0.97
Net Nonoperating Obligations (NNO)
0.00 -2.76 -3.42 -3.48 -2.17 -19 -15 -11 -7.78 -1.86
Total Depreciation and Amortization (D&A)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 193.46% 82.46% 15.37% 25.50% -285.61% 7.70% 57.10% 7.55% 71.61%
Debt-free Net Working Capital to Revenue
0.00% 479.59% 338.98% 229.82% 154.56% 16,896.46% 2,897.20% 1,007.93% 245.31% 110.46%
Net Working Capital to Revenue
0.00% 469.57% 338.98% 229.82% 154.56% 16,896.46% 2,897.20% 1,007.93% 245.31% 110.46%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 ($1.25) ($1.66) ($2.03) ($1.49)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 142.78M 163.22M 178.28M 227.25M 227.80M 227.80M 228.00M 233.96M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 ($1.49)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 142.78M 163.22M 178.28M 227.25M 227.80M 227.80M 228.00M 233.96M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 142.78M 163.22M 178.28M 227.25M 227.80M 227.80M 228.00M 233.96M
Normalized Net Operating Profit after Tax (NOPAT)
-3.71 -3.62 -1.58 -2.55 -1.41 -4.01 -1.39 -1.66 -2.71 -2.46
Normalized NOPAT Margin
-194.69% -337.06% -115.68% -153.25% -80.76% -3,659.12% -262.53% -138.43% -82.82% -51.34%
Pre Tax Income Margin
-278.29% -487.33% -166.51% -196.65% -116.23% -5,751.62% -373.01% -209.81% -141.49% -71.58%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 -61.26 0.00 0.00 0.00 0.00 -464.08 -403.36 -958.01 -731.56
NOPAT to Interest Expense
0.00 -52.49 0.00 0.00 0.00 0.00 -324.86 -258.83 -536.06 -512.10
EBIT Less CapEx to Interest Expense
0.00 -61.33 0.00 0.00 0.00 0.00 -465.71 -404.16 -958.03 -731.56
NOPAT Less CapEx to Interest Expense
0.00 -52.55 0.00 0.00 0.00 0.00 -326.48 -259.63 -536.08 -512.10
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -2.38%

Quarterly Metrics And Ratios for Immuron

No quarterly metrics and ratios for Immuron are available.



Financials Breakdown Chart

Immuron Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Immuron's fiscal year ends in June. Their fiscal year 2025 ended on June 30, 2025.

Immuron's net income appears to be on a downward trend, with a most recent value of -$3.43 million in 2025, falling from -$5.30 million in 2016. The previous period was -$4.63 million in 2024. Find out what analysts predict for Immuron in the coming months.

Immuron's total operating income in 2025 was -$3.51 million, based on the following breakdown:
  • Total Gross Profit: $3.13 million
  • Total Operating Expenses: $6.65 million

Over the last 9 years, Immuron's total revenue changed from $1.91 million in 2016 to $4.79 million in 2025, a change of 151.4%.

Immuron's total liabilities were at $1.35 million at the end of 2025, a 28.6% decrease from 2024, and a 3.0% increase since 2017.

In the past 8 years, Immuron's cash and equivalents has ranged from $1.86 million in 2025 to $18.82 million in 2021, and is currently $1.86 million as of their latest financial filing in 2025.

Over the last 9 years, Immuron's book value per share changed from 0.00 in 2016 to 0.02 in 2025, a change of 2.3%.



Financial statements for NASDAQ:IMRN last updated on 9/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners